PROTALIX BIOTHERAPEUTICS INC

CUSIP: 74365AAD3 Class: BOND

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 8,000,000 Value ($000) $7,840,000 Avg Close — Range —
Q1 2021
Shares 8,000,000 Value ($000) $7,840,000 Avg Close — Range —
Q4 2020
Shares 8,000,000 Value ($000) $7,440,000 Avg Close — Range —
Q3 2020
Shares 8,000,000 Value ($000) $7,200,000 Avg Close — Range —
Q2 2020
Shares 8,000,000 Value ($000) $7,200,000 Avg Close — Range —
Q1 2020
Shares 8,000,000 Value ($000) $7,200,000 Avg Close — Range —
Q4 2019
Shares 8,000,000 Value ($000) $7,120,000 Avg Close — Range —
Q3 2019
Shares 8,000,000 Value ($000) $7,628,000 Avg Close — Range —
Q2 2019
Shares 8,000,000 Value ($000) $7,628,000 Avg Close — Range —
Q4 2018
Shares 8,000,000 Value ($000) $7,360,000 Avg Close — Range —
Q3 2018
Shares 8,000,000 Value ($000) $7,620,000 Avg Close — Range —
Q2 2018
Shares 8,000,000 Value ($000) $7,200,000 Avg Close — Range —
Q1 2018
Shares 7,000,000 Value ($000) $6,816,000 Avg Close — Range —
Q4 2017
Shares 9,000,000 Value ($000) $8,638,000 Avg Close — Range —
Q3 2017
Shares 4,000,000 Value ($000) $3,200,000 Avg Close — Range —
Q2 2017
Shares 6,579,000 Value ($000) $5,263,000 Avg Close — Range —
Q1 2017
Shares 7,525,000 Value ($000) $6,020,000 Avg Close — Range —
Q4 2016
Shares 8,525,000 Value ($000) $6,956,000 Avg Close — Range —